The tell-tale heart: population-based surveillance reveals an association of rofecoxib and celecoxib with myocardial infarction
about
Making big data useful for health care: a summary of the inaugural MIT critical data conferenceSHRINE: enabling nationally scalable multi-site disease studiesThe coming age of data-driven medicine: translational bioinformatics' next frontierDynamic clinical data mining: search engine-based decision supportNovel data-mining methodologies for adverse drug event discovery and analysisThe Drug Data to Knowledge Pipeline: Large-Scale Claims Data Classification for Pharmacologic InsightPharmacovigilance Using Clinical NotesReusing electronic patient data for dental clinical research: a review of current status.Using electronic dental record data for research: a data-mapping study.Rediscovering drug side effects: the impact of analytical assumptions on the detection of associations in EHR dataMeasuring population health using personal health messages.Medication-wide association studies.Mechanisms of Kv2.1 channel inhibition by celecoxib--modification of gating and channel blockPatient stratification and identification of adverse event correlations in the space of 1190 drug related adverse events.Translational bioinformatics embraces big data.The development of a dental diagnostic terminologyThe emerging role of electronic medical records in pharmacogenomics.A translational engine at the national scale: informatics for integrating biology and the bedside.The future of genomics in pathology.Supporting Multi-sourced Medication Information in i2b2Combing signals from spontaneous reports and electronic health records for detection of adverse drug reactionsInterpreting noncoding genetic variation in complex traits and human disease.Electronic medical records as a tool in clinical pharmacology: opportunities and challenges.Prostaglandin E(2) synthase inhibition as a therapeutic target.Using electronic health records to drive discovery in disease genomics.Integrative genomics strategies to elucidate the complexity of drug response.Effectiveness and safety of topical versus oral nonsteroidal anti-inflammatory drugs: a comprehensive review.The Cardiovascular Pharmacology of Nonsteroidal Anti-Inflammatory Drugs.Phenome based analysis as a means for discovering context dependent clinical reference ranges.A pharmacoepidemiological network model for drug safety surveillance: statins and rhabdomyolysis.The influence of big (clinical) data and genomics on precision medicine and drug development.A comparison of the empirical performance of methods for a risk identification system.Clinical epidemiology: Archived answers.Drug discovery. Repurposing with a difference.
P2860
Q24273403-FD2A63AA-8D7E-4E12-B0D2-C7FEFBB0C39FQ24288701-D11EE774-50C4-47F8-AF5E-7D1FFA30BA5FQ28386235-A57ED15B-8FED-46F7-8172-A98AE8ECC174Q28652473-F692675C-C52B-4A3D-8CAF-BD5D3BC1A33DQ28681788-2B06051B-B0F5-4676-93C4-9E9E7FD98972Q28828690-CB313057-0D95-49A4-8037-C43EAC2BD56FQ30058397-A363BAC4-AF69-4C91-8CDC-EE5F4F86BA1EQ30619243-DB6F1949-FAB3-4C2C-B07A-EFBD6C6C6C6EQ30629581-3AEBE5F5-B27B-427B-855A-A8E3994C2994Q30989677-893654CB-89C9-46AA-A8DD-84482199CEAAQ33626647-2B712051-B0C2-49E2-8634-B71BCD591B21Q33633627-6901CF73-5D7E-45E0-B145-92D7A475F48FQ33673130-ECACD509-4B58-4169-9F7D-B8EDCF6A28ADQ34154208-AC84B9AD-A36F-485B-871E-7B577CA40FB7Q34378848-4CAD718F-D4CC-41AD-8C68-9555FF1833C6Q35023375-87D1E8A5-85E5-4155-89DC-5D8027509333Q35478918-70F69984-6762-4467-887E-511A313835CEQ35751228-7D9820AE-701D-46B0-B78D-1A891ACD8ECAQ36082163-EB6571CA-5941-49CF-89BA-AAE1936A9F8EQ36613178-9987D543-9CDE-417C-A3CF-61C934EC0353Q36771112-2D6C50B0-4A38-4D20-B430-3154435115EFQ36988784-2090538D-7194-412B-9B64-E498C9A22117Q37286031-BFA80750-5377-4280-9106-9C03907DC451Q37521092-6C6ECD91-9CF7-43D2-939D-15AC25E8819BQ37876693-1FC42B12-E0D9-4561-9FD6-93CB8BB5A3A2Q37961088-DD53F598-94FF-4661-9AC2-3B5751F18F5EQ38109089-D2AB8CF9-AF34-40BA-8B66-BEB804F3DD8FQ39399193-7FFC2673-4301-4BB5-B297-80360EF4B00BQ41887782-11E90C11-80D5-4344-915C-589E9DF69E68Q44834340-F40F6B34-DA10-485B-9108-4074084FA62DQ45943634-D4AD0564-1C4F-48B5-B75F-735C3563D2A4Q46050855-D844FFF3-8756-4CC1-8C2E-2A054BE29178Q46084063-77C7563E-6D46-4B6F-B168-F682B485F5A1Q55051971-87C000C5-9666-4931-9A7F-092F350C0631
P2860
The tell-tale heart: population-based surveillance reveals an association of rofecoxib and celecoxib with myocardial infarction
description
2007 nî lūn-bûn
@nan
2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
The tell-tale heart: populatio ...... xib with myocardial infarction
@ast
The tell-tale heart: populatio ...... xib with myocardial infarction
@en
The tell-tale heart: populatio ...... ib with myocardial infarction.
@nl
type
label
The tell-tale heart: populatio ...... xib with myocardial infarction
@ast
The tell-tale heart: populatio ...... xib with myocardial infarction
@en
The tell-tale heart: populatio ...... ib with myocardial infarction.
@nl
prefLabel
The tell-tale heart: populatio ...... xib with myocardial infarction
@ast
The tell-tale heart: populatio ...... xib with myocardial infarction
@en
The tell-tale heart: populatio ...... ib with myocardial infarction.
@nl
P2860
P1433
P1476
The tell-tale heart: populatio ...... xib with myocardial infarction
@en
P2093
Kenneth D Mandl
Margarita Sordo
P2860
P356
10.1371/JOURNAL.PONE.0000840
P407
P577
2007-09-05T00:00:00Z